ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

CELU Celularity Inc

3.3083
0.1883 (6.04%)
最終更新日: 04:58:52
15分遅延
名称 銘柄コード 市場 種別
Celularity Inc CELU NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.1883 6.04% 3.3083 04:58:52
始値 安値 高値 終値 前日終値
3.21 3.08 3.32 3.12
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/2221:00GLOBECelularity Inc. to Host Investor and Analyst Research &..
2024/4/2006:30GLOBECelularity Inc. Announces Receipt of Nasdaq Notice Regarding..
2024/4/1905:30GLOBECelularity Abstract “Emerging Technologies for the..
2024/4/1521:00GLOBECelularity Announces Net Sales Trending Ahead of..
2024/4/0822:00GLOBECelularity to Present Data Showing Senescent Cell..
2024/3/2622:00GLOBECelularity Receives Healthcare Common Procedure Coding..
2024/3/2022:15GLOBECelularity Submits Request to U.S. FDA for Orphan Drug..
2024/3/1422:15GLOBECelularity CEO to Present on Cell Therapy’s Potential to..
2024/3/1222:20GLOBECelularity CEO to Present Keynote Address at 2024 Society..
2024/3/0723:35GLOBECelularity to Present Data Showing Cancer Tumor Reduction by..
2024/2/2707:15EDGAR2Form 8-K - Current report
2024/2/2406:10GLOBECelularity Announces 1-for-10 Reverse Stock Split
2024/2/2223:05EDGAR2Form 8-K - Current report
2024/2/2211:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2211:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2211:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2211:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2211:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1506:05GLOBECelularity’s Tri-layer Decellularized, Dehydrated Human..
2024/2/1306:15EDGAR2Form 8-K - Current report
2024/2/0220:01EDGAR2Form DEF 14A - Other definitive proxy statements
2024/2/0123:00GLOBECelularity Announces Net Sales Expectations for First..
2024/1/2523:00GLOBECelularity and Genting Leaders Comments on Closing $21..
2024/1/2320:02EDGAR2Form PRE 14A - Other preliminary proxy statements
2024/1/1903:40GLOBECelularity Releases CEO Letter to Shareholders
2024/1/1807:15EDGAR2Form SC 13D/A - General statement of acquisition of..
2024/1/1806:14EDGAR2Form 8-K - Current report
2024/1/1006:49EDGAR2Form 8-K - Current report
2024/1/0503:00GLOBECelularity Confirms Commercialization Agreement with..
2024/1/0402:00GLOBECelularity Announces Net Sales and Total Revenue..
2023/12/3006:47EDGAR2Form 8-K - Current report
2023/11/2503:46EDGAR2Form 8-K - Current report
2023/11/2503:15GLOBECelularity Inc. Announces Receipt of Nasdaq Notice Regarding..
2023/10/1822:00GLOBECelularity Announces Commercial Biomaterial Products..
2023/10/1709:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/1708:44EDGAR2Form 3 - Initial statement of beneficial ownership of..
2023/9/1922:25EDGAR2Form 8-K - Current report
2023/9/0805:21EDGAR2Form 8-K - Current report
2023/9/0805:10GLOBECelularity Appoints Geoffrey Shiu Fei Ling, M.D., Ph.D. to..
2023/8/2922:15EDGAR2Form 8-K - Current report
2023/8/2922:00GLOBECelularity Announces Multi-Year Research Collaboration..
2023/8/2605:06EDGAR2Form 8-K - Current report
2023/8/1506:24EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/0505:16EDGAR2Form 8-K - Current report
2023/7/2905:27EDGAR2Form 8-K - Current report
2023/7/2905:24EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/7/2722:07GLOBECelularity Inc. Announces $3 Million Registered Direct..
2023/7/2722:00GLOBECelularity and Verséa Ophthalmics Announce Exclusive U.S...
2023/7/2001:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/7/1822:00GLOBECelularity Human Placental-Derived Advanced Biomaterials..

最近閲覧した銘柄

Delayed Upgrade Clock